The interdisciplinary, research-oriented Molecular & Cell Biology & Genetics program offers both MS and PhD degrees. The program provides a broad education-training program for graduate students ...

Rare genetic disorders are typically caused by a variant in a single gene. It is estimated that there are over 7000 such conditions, meaning that although individually rare, they are collectively ...

Helge Zieler, PhD, believes in the promise of biologic and genetic medicines. But for any new medicine based on nucleic acids or proteins, it’s all for nothing if the biomolecule cannot be made after ...

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populations.

– Immune-quiet DNA (iqDNA) is a novel variant of closed-ended DNA (ceDNA) that evades host innate immune detection in both mice and non-human primates (NHPs) with a systemic cytokine profile and ...

A newly identified class of RNA molecules has been discovered in bacteria living inside the human body. These circular ...

Moderna will apply Generation Bio’s proprietary stealth cell-targeted lipid nanoparticle (ctLNP) delivery system to discover and develop non-viral genetic medicines for immune system and liver ...

Update: Story updated with Generation Bio premarket stock movement. Moderna (NASDAQ:MRNA) is collaborating with Generation Bio (NASDAQ:GBIO) to develop non-viral genetic medicines. The collaboration ...